Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

Overview of attention for article published in BMC Cancer, December 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 260 followers.

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases. https://t.co/9vmGIUJCtx

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.